Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

The Komdigi Ministry issued a third warning letter to X for not meeting its obligation to pay the previously determined ...